Skip to the page

Data / Form D filings / Genvax Technologies, Inc.

Genvax Technologies, Inc.: Form D filings

Genvax Technologies, Inc., a company in Ames, IA, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on June 24, 2024, reports $3.4 million sold of a $5.2 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2503 S. LOOP DRIVE, Ames, IA, 50010
Phone
(515) 686-4676
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1940166

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 24, 2024New notice$5,249,991$3,399,985$1,850,0069Jun 7, 2024sec.gov
Aug 9, 2022New notice$6,370,000$6,370,00020Jun 2, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joel HarrisExecutive Officer, Director
Trent TorranceDirector
DL Hank HarrisDirector

Other companies in Iowa that filed recently

Every Form D from the week of Jun 24, 2024 · All recent filings in Iowa · All recent Other filings

Read from SEC EDGAR. Amount sold is what Genvax Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.